INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 239 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $951,962 | -8.4% | 24,927 | -1.3% | 0.17% | -4.4% |
Q2 2023 | $1,039,149 | -2.1% | 25,265 | +36.6% | 0.18% | -3.2% |
Q1 2023 | $1,061,741 | +34.2% | 18,494 | -0.9% | 0.19% | +25.5% |
Q3 2022 | $791,000 | -17.4% | 18,665 | +5.2% | 0.15% | -10.2% |
Q2 2022 | $958,000 | -6.3% | 17,738 | +16.3% | 0.17% | +12.2% |
Q4 2021 | $1,022,000 | -6.8% | 15,250 | -4.7% | 0.15% | +18.4% |
Q3 2021 | $1,096,000 | +4.7% | 16,008 | -10.9% | 0.12% | -16.1% |
Q4 2020 | $1,047,000 | +17.4% | 17,965 | -5.4% | 0.15% | +3.5% |
Q2 2020 | $892,000 | -6.3% | 18,986 | -10.9% | 0.14% | -22.6% |
Q1 2020 | $952,000 | -19.9% | 21,305 | +4.5% | 0.19% | +16.2% |
Q4 2019 | $1,188,000 | -3.5% | 20,390 | -0.5% | 0.16% | -8.0% |
Q3 2019 | $1,231,000 | +7.6% | 20,500 | +0.1% | 0.17% | +15.2% |
Q2 2019 | $1,144,000 | +205.1% | 20,485 | +196.0% | 0.15% | +135.9% |
Q4 2014 | $375,000 | -78.0% | 6,920 | -85.2% | 0.06% | -82.6% |
Q2 2013 | $1,708,000 | – | 46,637 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |